Translocation Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Immune and Genomic Markers in ALK+ NSCLC
Conditions:   Anaplastic Lymphoma Kinase Gene Translocation;   Non-Small Cell Lung Cancer Intervention:   Sponsors:   Massachusetts General Hospital;   Lungevity Foundation;   Addario Lung Cancer Medical Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 11, 2021 Category: Research Source Type: clinical trials